# LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer

> **NCT01561443** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 153 (actual)

## Conditions studied

- Local Advanced or Metastatic Postmenopausal Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01561443
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2016-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561443, "LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01561443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*